Items where Subject is "32 BIOMEDICAL AND CLINICAL SCIENCES > 3211 Oncology and carcinogenesis > 321104 Cancer therapy (excl. chemotherapy and radiation therapy)"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0 [feed] RSS 2.0
Group by: Creators | Item Type
Jump to: A | H | K | L | N | O | R | S | Z | Á
Number of items at this level: 19.

A

Adeoye, John, Tan, Jia Yan, Choi, Siu-Wai, and Thomson, Peter (2021) Prediction models applying machine learning to oral cavity cancer outcomes: a systematic review. International Journal of Medical Informatics. 104557. (In Press)

Au, Minnie, Emeto, Theophilus I., Power, Jacinta, Vangaveti, Venkat N., and Lai, Hock C. (2016) Emerging therapeutic potential of nanoparticles in pancreatic cancer: a systematic review of clinical trials. Biomedicines, 4 (3). 20. pp. 1-20.

H

Han, Shuanglin, Latchoumanin, Olivier, Wu, Guang, Zhou, Gang, Hebbard, Lionel, George, Jacob, and Qiao, Liang (2017) Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumors. Cancer Letters, 390. pp. 188-200.

Hafeez, Umbreen, Joshi, Abhishek, Bhatt, Manoj, Kelly, Jenny, Sabesan, Sabe, and Vangaveti, Venkat (2017) Clinical profile and treatment outcomes of advanced neuroendocrine tumours in rural and regional patients: a retrospective study from a regional cancer centre in North Queensland, Australia. Internal Medicine Journal, 47 (3). pp. 284-290.

K

Keene, Martin, Heslop, Ian M., Sabesan, Sabe S., and Glass, Beverley D. (2020) Knowledge, attitudes and practices of health professionals toward complementary and alternative medicine in cancer care–a systematic review. Journal of Communication in Healthcare, 13 (3). pp. 205-218.

Keene, Martin R., Heslop, Ian M., Sabesan, Sabe S., and Glass, Beverley D. (2019) Complementary and alternative medicine use in cancer: a systematic review. Complementary Therapies in Clinical Practice, 35. pp. 33-47.

Karakiewicz, Pierre I., Nott, Louise, Joshi, Abhishek, Kannourakis, George, Tarazi, Jamal, and Alam, Mahmood (2016) Evaluation of response from axitinib per response evaluation criteria in solid tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma. OncoTargets and Therapy, 9. pp. 2855-2863.

L

Lai, Xin, Eberhardt, Martin, Schmitz, Ulf, and Vera, Julio (2019) Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer. Nucleic Acids Research, 47 (15). pp. 7753-7766.

Lai, Xin, Gupta, Shailendra K., Schmitz, Ulf, Marquardt, Stephan, Knoll, Susanne, Spitschak, Alf, Wolkenhauer, Olaf, Pützer, Brigitte M., and Vera, Julio (2018) MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance. Theranostics, 8 (4). pp. 1106-1120.

Levin, Gregory T., Greenwood, Kenneth M., Singh, Favil, Tsoi, Daphne, and Newton, Robert U. (2016) Exercise improves physical function and mental health of brain cancer Survivors: two exploratory case studies. Integrative Cancer Therapies, 15 (2). pp. 190-196.

N

Ndjavera, Wilphard, Orange, Samuel T., O'Doherty, Alasdair F., Leicht, Anthony S., Rochester, Mark, Mills, Robert, and Saxton, John M. (2020) Exercise-induced attenuation of treatment side-effects in patients with newly diagnosed prostate cancer beginning androgen-deprivation therapy: a randomised controlled trial. BJU International, 125 (1). pp. 28-37.

Nath, Karthik, Boles, Rachael, McCutchan, Andrew, Vangaveti, Venkat, Birchley, Andrew, and Irving, Ian (2018) The relationship between CD34+ stem cell dose and time to neutrophil recovery in autologous haematopoietic stem cell recipients: a single centre experience. Transfusion and Apheresis Science, 57 (4). pp. 532-536.

O

Oates, R., Brown, A., Tan, A., Foroudi, F., Joon, M. Lim, Schneider, M., Herschtal, A., and Kron, T. (2017) Real-time image-guided adaptive-predictive prostate radiotherapy using rectal diameter as a predictor of motion. Clinical Oncology, 29 (3). pp. 180-187.

R

Ranasinghe, Shiwanthi L., Boyle, Glen M., Fischer, Katja, Potriquet, Jeremy, Mulvenna, Jason P., and McManus, Donald P. (2018) Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer. PLoS ONE, 13 (8). e0200433.

Razaghi, Ali, Heimann, Kirsten, Schaeffer, Patrick M., and Gibson, Spencer B. (2018) Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies. Apoptosis, 23 (2). pp. 93-112.

Razaghi, Ali, Villacrés, Carina, Jung, Vincent, Mashkour, Narges, Butler, Michael, Owens, Leigh, and Heimann, Kirsten (2017) Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells. Experimental Cell Research, 359 (1). pp. 20-29.

S

Schenk, Jeannette, Till, Cathee, Hsing, Ann W., Stanczyk, Frank Z., Gong, Zhihong, Neuhouser, Marian L., Reichardt, Juergen K., Hoque, Ashraful M., Figg, William D., Goodman, Phyllis J., Tangen, Catherine M., and Thompson, Ian (2016) Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial. Cancer Causes and Control, 27 (2). pp. 175-182.

Z

Zhou, Gang, Latchoumanin, Olivier, Hebbard, Lionel, Duan, Wei, Liddle, Christopher, George, Jacob, and Qiao, Liang (2018) Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers. Advanced Drug Delivery Reviews, 134. pp. 107-121.

Á

Ávila, Mónica, Patel, Laila, López, Silvia, Cortés-Sanabria, Laura, Garin, Olatz, Pont, Àngels, Ferrer, Ferran, Boladeras, Ana, Zamora, Victor, Fosså, Sophie, Storås, Anne H., Sanda, Martin, Serra-Sutton, Vicky, and Ferrer, Montse (2018) Patient-reported outcomes after treatment for clinically localized prostate cancer: a systematic review and meta-analysis. Cancer Treatment Reviews, 66. pp. 23-44.

This list was generated on Mon Dec 6 22:44:33 2021 AEST.